Brief: Rhovac Q4 Pretax Result Swings To Loss Of SEK 15.2 Mln

Chosa Oncology AB

12/02/2021 07:40

Feb 12 (Reuters) - RhoVac AB  RHOVAC.TE :
    * Q4 NET SALES SEK 0 VERSUS SEK 6 MILLION YEAR AGO
    * Q4 PRETAX LOSS SEK 15.2 MILLION VERSUS PROFIT SEK 4.5
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr8lpMgf 
Further company coverage:  RHOVAC.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))